Cereghetti A - Search Results

1

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: cereghetti a. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.

2

Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma.

Ferretti LP, Böhi F, Leslie Pedrioli DM, Cheng PF, Ferrari E, Baumgaertner P, Alvarado-Diaz A, Sella F, Cereghetti A, Turko P, Wright RH, De Bock K, Speiser DE, Ferrari R, Levesque MP, Hottiger MO. Ferretti LP, et al. Among authors: cereghetti a. Cancer Res. 2023 Dec 1;83(23):3974-3988. doi: 10.1158/0008-5472.CAN-23-0485. Cancer Res. 2023. PMID: 37729428

3

Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.

Mottas I, Bekdemir A, Cereghetti A, Spagnuolo L, Yang YS, Müller M, Irvine DJ, Stellacci F, Bourquin C. Mottas I, et al. Among authors: cereghetti a. Biomaterials. 2019 Jan;190-191:111-120. doi: 10.1016/j.biomaterials.2018.10.031. Epub 2018 Oct 25. Biomaterials. 2019. PMID: 30415018

4

[Take nothing for granted....what to do when accused of polypragmasy].

Cereghetti A, Pelet O. Cereghetti A, et al. Rev Med Suisse. 2008 Oct 29;4(177):2356-9. Rev Med Suisse. 2008. PMID: 19055154 French. No abstract available.

5

[No one is expected to ignore... the legal status of drug promotional studies].

Cereghetti A. Cereghetti A. Rev Med Suisse. 2006 Oct 11;2(82):2307-10. Rev Med Suisse. 2006. PMID: 17124859 French. No abstract available.

6

[Patient confidentiality].

Cereghetti A. Cereghetti A. Rev Med Suisse. 2006 Mar 8;2(56):682, 684-6. Rev Med Suisse. 2006. PMID: 16597059 French. No abstract available.

7

[The influence of justice in the prevention and treatment of AIDS].

Cereghetti A. Cereghetti A. Rev Med Suisse. 2005 Sep 14;1(32):2117-9. Rev Med Suisse. 2005. PMID: 16238233 Review. French. No abstract available.

8

[The fate of drug addicts managed with methadone in the Canton of Vaud (1976-1986). 2].

Meystre-Agustoni G, Martin J, Haller-Maslov E, Calanca A, Cereghetti A. Meystre-Agustoni G, et al. Among authors: cereghetti a. Rev Med Suisse Romande. 1988 Jun;108(6):501-19. Rev Med Suisse Romande. 1988. PMID: 3413400 French. No abstract available.

9

[The fate of drug addicts, taken care of by methadone therapy in the Canton of Vaud (1976-1986)].

Meystre-Agustoni G, Martin J, Haller-Maslov E, Calanca A, Cereghetti A. Meystre-Agustoni G, et al. Among authors: cereghetti a. Rev Med Suisse Romande. 1988 Mar;108(3):231-56. Rev Med Suisse Romande. 1988. PMID: 3375692 French. No abstract available.

10

[Follow-up of substance-dependent patients treated with methadone in the canton of Vaud (1976-1986)--preliminary results].

Meystre-Agustoni G, Martin J, Cereghetti A, Haller-Maslov E. Meystre-Agustoni G, et al. Among authors: cereghetti a. Soz Praventivmed. 1987;32(4-5):240-2. doi: 10.1007/BF02133837. Soz Praventivmed. 1987. PMID: 3687217 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page